SLC2A1 and neoplasm: To achieve precise targeting, theranostic molecule 5 (λmax-em = 726 nm) was designed and targeted against the high expression of the glucose transporter GLUT1, which occurs on the surface of highly proliferating tumour cells depending on glucose as a preferential energy source [26].